| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6189859 | Brachytherapy | 2013 | 12 Pages |
Abstract
BT is a useful component of the treatment of STS. The advantages of BT are the targeted dose distribution, low integral dose, and short treatment times. Ultimately the clinician should select the modality or combination of modalities that are most familiar to the treatment team and suitable to the patient.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Caroline L. Holloway, Thomas F. DeLaney, Kaled M. Alektiar, Phillip M. Devlin, Desmond A. O'Farrell, D. Jeffrey Demanes,